Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06023940 · ClinicalTrials.gov registry record · NA
Variability in Microbial Response to Dietary Fiber
A NA study of Microbial Colonization, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06023940: Completed NA study of Microbial Colonization, sponsored by University of Missouri-Columbia.
NCT06023940 is a NA study of Microbial Colonization that has completed, run by University of Missouri-Columbia. The registered enrollment target is 30 participants, below the 12,653-participant average among 20 other Microbial Colonization trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06023940, a NA study of Microbial Colonization, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to understand varying in responses to different dietary patterns in healthy people who are getting a health screening colonoscopy. The main questions it aims to answer are: * What is the variability in the change of the microbes in the gut of (1) a provided diet that is high in fiber vs (2) a diet of the participant's choice. * What is the magnitude of fasting changes in glucose and lipids following the short-term, high-fiber feeding period and identify candidate predictive factors (short-chain fatty acids, BMI, sex, starting glucose level) for these changes Participants will be in one of two groups: 1. High-fiber diet group: These participants will have a series of measurements that include: blood biochemistries, body composition measured via DEXA, anthropometrics, surveys and questionnaires, and collection of fecal samples. 2. Normal diet group: These participants will eat a diet that is of their choosing (ad libitum) and will have a series of measurements that include: fecal samples, and questionnaires/surveys including food records.
Primary Outcome
Measured via fecal sample. Intervention group - measured once before scheduled health screening colonoscopy and 2 times over 2 weeks post-colonoscopy (day 1, 7, 14). Control group - measured once before scheduled health screening colonoscopy and 5 days over 2 weeks post-colonoscopy (day 3, 5, 8, 11, 14). Variability in microbial composition refers to how many different kinds of microbes are present in the fecal sample. We are testing the possibility that the more kinds of microbes, the healthi
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT High fiber
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-12 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
What the finished NCT06023940 record still lists
NCT06023940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 12,653-participant average among 20 other Microbial Colonization trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Microbial Colonization appearing as the primary indexed condition, and to 1 intervention - of which High fiber is the first listed.
NCT06023940 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06023940 about?
NCT06023940 is a clinical study titled "Variability in Microbial Response to Dietary Fiber". The goal of this clinical trial is to understand varying in responses to different dietary patterns in healthy people who are getting a health screening colonoscopy. The main questions it aims to answer are: * What is the variability in the change of the microbes in the gut of (1) a provided diet ...
What is the current status of trial NCT06023940?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-05-12. Estimated completion is 2023-10-31.
What conditions does trial NCT06023940 study?
This clinical trial studies the following conditions: Microbial Colonization.
What interventions are being tested in trial NCT06023940?
The interventions under investigation include: High fiber (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06023940?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06023940 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microbial Colonization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06023940's enrollment target sits among peer trials
30 16th of 20 higher than 4 of 20 other Microbial Colonization trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Microbial Colonization trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Gut Microbiota-dependent Health Impacts of Haskap Berries
RECRUITING · NA
-
Pilot Haskap Metabolite Timing Project
ACTIVE NOT RECRUITING · NA
-
An Examination of Infants' Microbiome, Nutrition, and Development Study.
ACTIVE NOT RECRUITING · NA
-
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI